Key terms
About ACON
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ACON news
Yesterday
9:17am ET
Aclarion’s Nociscan solution to be utilized in LIFEHAB trial
Mar 06
3:55pm ET
Aclarion, Inc. (ACON) Gets a Buy from Maxim Group
Mar 04
8:15am ET
Aclarion announces publication of peer-reviewed data in journal on lumbar discs
Feb 26
9:19am ET
Aclarion prices 5.175M units at 58c in public offering
Feb 21
5:42pm ET
Aclarion, Inc. Clarifies Unfiled Financial Disclosure Status
Feb 05
8:09am ET
Aclarion plans to launch CLARITY trial, provides update on Alphatec partnership
ACON Financials
Key terms
Ad Feedback
ACON Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ACON Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
